[Inhibition of RANK-L in the pathophysiology of osteoporosis. Clinical evidences of its use]. [electronic resource]
- Ginecologia y obstetricia de Mexico Mar 2013
- 146-57 p. digital
Publication Type: English Abstract; Journal Article; Review
0300-9041
Antibodies, Monoclonal, Humanized--therapeutic use Denosumab Female Humans Osteoporosis, Postmenopausal--etiology RANK Ligand--antagonists & inhibitors Randomized Controlled Trials as Topic